Instrument Inactif

Communiqués Arena Pharmaceuticals

Actions

ARNA

US0400476075

Communiqués

11/03/22	Arena Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	PU
11/03/22	ARENA PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	AQ
10/03/22	ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
23/02/22	ARENA PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-K)	AQ
23/02/22	Arena Pharmaceuticals : Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates - Form 8-K	PU
23/02/22	Arena Reports Fourth Quarter and Full Year 2021 Financial Results and Key Program Updates	BU
18/02/22	ARENA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	AQ
17/02/22	Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
09/02/22	Arena Pharmaceuticals to Release Fourth Quarter and Full-Year 2021 Financial Results and Provide Corporate Update on February 23	BU
07/02/22	ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
02/02/22	ARENA PHARMACEUTICALS INC : Submission of Matters to a Vote of Security Holders (form 8-K)	AQ
19/01/22	Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(4)	AQ
18/01/22	Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
07/01/22	ARENA PHARMACEUTICALS INC : Other Events (form 8-K)	AQ
22/12/21	ARENA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	AQ
21/12/21	Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
13/12/21	Pfizer to pay $6.7B in cash for Arena Pharmaceuticals	AQ
13/12/21	Arena Pharmaceuticals : Joint Press Release of Pfizer Inc. and Arena Pharmaceuticals, Inc., dated as of December 13, 2021 - Form 8-K	PU
13/12/21	ARENA PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Change in Directors or Principal Officers, Other Events, Financial Statements and Exhibits (form 8-K)	AQ
19/11/21	Arena Pharmaceuticals Achieves Target Enrollment for Etrasimod CULTIVATE Study A	BU
17/11/21	ARENA PHARMACEUTICALS REPORTS INDUCEMENT GRANTS UNDER NASDAQ LISTING RULE 5635(4)	AQ
16/11/21	Arena Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)	BU
04/11/21	ARENA PHARMACEUTICALS INC Management's Discussion and Analysis of Financial Condition and Results of Operations. (form 10-Q)	AQ
04/11/21	Arena Reports Third Quarter Financial Results and Key Program Updates - Form 8-K	PU
04/11/21	Arena Reports Third Quarter Financial Results and Key Program Updates	BU